Equities
Basic MaterialsChemicals
  • Price (GBX)2,884.00
  • Today's Change-22.00 / -0.76%
  • Shares traded750.01k
  • 1 Year change-7.30%
  • Beta1.2639
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Croda International Plc is a United Kingdom-based specialty chemicals company. The Company uses its smart science to create performance ingredients and technologies that improve people's lives. Its sales, marketing and research activities are organized into three global market sectors: consumer care, life sciences, and industrial specialties. Its consumer care sector's business units comprise beauty actives, fragrances and flavors, beauty care, and home care. The Company's life sciences sector's business units comprise agriculture (crop protection and seed enhancement) and pharma. The crop protection unit offers ingredients that improve performance and delivery of crop formulations. The pharma comprises drug delivery, providing excipients and adjuvants for drugs through synthesis, purification, formulation and application technology. Seed enhancement is a technology used to improve germination, stimulate the development of seeds and increase crop yields.

  • Revenue in GBP (TTM)1.67bn
  • Net income in GBP139.90m
  • Incorporated1925
  • Employees6.03k
  • Location
    Croda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 140 586 0551
  • Fax+44 140 586 1767
  • Websitehttps://www.croda.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
K+S AG3.17bn-1.48bn2.19bn11.36k--0.5894--0.6903-9.49-9.4920.3223.800.44334.575.44317,413.70-20.704.08-22.484.8211.9221.93-46.7010.052.33--0.103919.65-5.677.46-131.82--0.632430.26
Solvay SA4.27bn134.06m2.49bn8.67k18.662.355.800.58321.451.4546.4011.520.76286.546.77565,809.202.522.593.433.4021.2424.793.304.201.048.610.635978.01-14.84-14.50270.23---19.76-8.31
Clariant AG3.86bn107.31m2.60bn10.27k24.081.426.860.67320.34210.342112.305.820.66763.786.73388,246.502.432.493.373.6131.8029.563.643.710.89936.670.496283.72-5.14-1.1545.24---6.28-32.51
Kemira Oyj2.45bn190.73m2.71bn4.77k14.661.837.271.111.411.4118.1511.290.8736--6.56598,914.407.205.969.437.98--37.458.246.441.2815.370.284753.39-12.872.0925.2617.75-3.615.73
Gubre Fabrikalari TAS896.85m102.33m2.86bn1.89k27.946.1321.633.1918.0417.70158.1082.261.015.989.2429,228,970.0011.850.431622.301.1722.8414.1911.680.3220.8961--0.2032---4.7261.98137.70--76.38--
Wacker Chemie AG4.85bn18.89m3.49bn16.62k174.140.89477.250.72050.44160.4416112.1785.950.63612.866.74334,573.500.43087.020.51758.7015.2821.690.67739.281.642.840.304648.76-10.633.03-23.15--9.4437.97
SOL SpA1.48bn136.06m3.69bn7.41k27.104.0012.942.481.721.7218.7911.680.78963.993.36233,844.907.627.889.7710.1874.3672.789.649.862.0413.820.414222.168.2912.231.3524.528.5017.38
Arkema SA8.04bn110.56m3.85bn21.15k34.780.60564.720.47851.671.67122.0095.950.6385.566.80438,098.800.9675.291.146.3618.6821.181.527.062.264.380.364536.030.31531.78-15.92-7.202.8610.35
Johnson Matthey PLC11.40bn-127.00m3.87bn10.64k--1.8496.720.3395-0.7474-0.759367.3812.501.9010.547.751,070,556.00-2.123.05-3.565.417.046.81-1.111.491.286.020.415365.12-9.10-4.34245.377.90-3.386.72
Croda International Plc1.67bn139.90m4.06bn6.03k29.041.8314.502.431.001.0011.9315.870.47362.454.59276,754.604.049.314.5710.6345.1046.268.5417.371.199.910.248547.86-3.923.40-7.31-6.6810.374.10
Umicore SA14.02bn112.14m4.22bn11.41k36.632.3211.110.30120.53720.537267.068.501.916.3812.701,390,302.001.720.39842.990.66667.766.540.8970.17550.72472.340.5876273.74-18.68-3.21-484.31---0.19165.92
Imcd NV4.19bn232.16m4.57bn5.28k19.382.6512.901.094.584.5882.6533.461.065.345.26939,651.805.857.007.899.4022.4821.915.546.061.044.720.467144.626.4111.94-4.8020.848.3419.03
Evonik Industries AG12.42bn81.83m5.95bn31.30k73.870.81835.510.47890.19850.200630.8517.920.74874.248.68446,789.800.5721.530.71611.8622.5625.060.7642.120.79786.760.3481176.60-0.72052.95147.74-21.67-0.92610.3454
Data as of Feb 06 2026. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX

Institutional shareholders

39.16%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 28 Aug 202512.93m9.26%
Massachusetts Financial Services Co.as of 06 Mar 20257.36m5.27%
Mawer Investment Management Ltd.as of 31 Dec 20216.44m4.61%
Select Equity Group LPas of 01 Jan 20265.76m4.12%
The Vanguard Group, Inc.as of 01 Jan 20265.32m3.81%
MFS International (UK) Ltd.as of 01 Jan 20264.62m3.31%
Royal London Asset Management Ltd.as of 01 Jan 20264.22m3.02%
Standard Investments LLCas of 15 Sep 20253.55m2.54%
BlackRock Investment Management (UK) Ltd.as of 26 Aug 20252.33m1.67%
Legal & General Investment Management Ltd.as of 01 Jan 20262.15m1.54%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.